Kepos Capital LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2019$935,000
-61.6%
19,363
-59.8%
0.10%
-48.1%
Q1 2019$2,436,000
-14.8%
48,2190.0%0.18%
-17.2%
Q4 2018$2,858,000
-10.0%
48,2190.0%0.22%
+35.6%
Q3 2018$3,174,000
+30.3%
48,2190.0%0.16%
+31.5%
Q2 2018$2,435,000
+356.0%
48,219
+375.8%
0.12%
+300.0%
Q1 2018$534,00010,1340.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Values First Advisors, Inc. 152,699$519,1780.34%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 299,187$1,017,0000.22%
Hilltop Holdings Inc. 235,019$799,0640.09%
AIMZ Investment Advisors, LLC 51,372$174,6650.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 868,605$2,953,2570.07%
PALISADE CAPITAL MANAGEMENT, LP 509,325$1,731,7050.05%
SHERBROOKE PARK ADVISERS LLC 41,417$140,8180.04%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2,428,490$8,256,8660.03%
Y-Intercept (Hong Kong) Ltd 75,362$256,2310.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,246,020$4,236,4680.02%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders